Aktie 002880 SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shenzhen Weiguang Biological Products Co., Ltd.

Aktien

002880

CNE100002Q58

002880

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 27.05.2024 		% 5 Tage % 1. Jan.
30.02 CNY +1.15% Intraday Chart für Shenzhen Weiguang Biological Products Co., Ltd. -1.15% -14.55%
2023 Weiguang Biological Products erhält Registrierungszertifikat für menschliches Gerinnungsfaktor VIII-Medikament MT
2023 Shenzhen Weiguang Biological Products Co., Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for the Year 2023
Weiguang Biological Products Gets Registration Certificate for Human Coagulation Factor VIII Drug
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Profit Distribution Plan to Be Implemdented (A Shares) for 2023, Payable on 31 October 2023
Shenzhen Weiguang Biological Products Co., Ltd. Announces Interim Dividend for Year 2023
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) added to S&P Global BMI Index
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2023
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Weiguang Biological Products Halts Trading on Potential Change in Control
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Goldport Capital, Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors
Weiguang Biological Products to Buy 80% of Plasma Collection Firm For 23 Million Yuan
Shenzhen Weiguang Biological Products Co., Ltd. agreed to acquire 80% stake in Ankang Huitian Plasmapheresis Station Co., Ltd. from Xia Yuzhen for CNY 22.8 million
Shenzhen Weiguang Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenzhen Weiguang Biological Products Co., Ltd. Announces Cash Dividend on A Shares for 2021, Payable on 8 July 2022
Shenzhen Weiguang Biological Products Co., Ltd.(XSEC:002880) dropped from S&P Global BMI Index
Shenzhen Weiguang Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021
Shenzhen Weiguang Biological Products Co., Ltd. Proposes Final Cash Dividend for 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 002880 Aktie
  4. Nachrichten Shenzhen Weiguang Biological Products Co., Ltd.
  5. Andere Sprachen